Pathologic Findings at Risk Reducing Surgery in <i>BRCA</i> and Non-<i>BRCA</i> Mutation Carriers: A Single-Center Experience

Risk-reducing surgery (RRS) is recommended in BRCA-mutated carriers because of their increased risk of developing ovarian cancer, while its role is still discussed for women harboring mutations in non-<i>BRCA</i> homologous repair genes. The aim of this study was to retrospectively evaluate the occu...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Chiara Cassani, Chiara Rossi, Cristina Angela Camnasio, Mario Urtis, Giacomo Fiandrino, Maurizia Grasso, Francesca Zanellini, Marco Lucioni, Gioacchino D’Ambrosio, Alessandro Di Toro, Margherita Rossi, Marianna Roccio, Alberta Ferrari, Simona Secondino, Rossella Elena Nappi, Eloisa Arbustini, Marco Paulli, Arsenio Spinillo, Stefania Cesari
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2022-12-01
Sarja:	Diagnostics
Aiheet:	serous tubal intraepithelial carcinoma risk-reducing surgery <i>TP53</i> <i>BRCA</i> high-grade serous carcinoma non-<i>BRCA</i> mutations
Linkit:	https://www.mdpi.com/2075-4418/12/12/3054
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!